Replies

Thanks for posting this article. The approval of Vyleesi by the FDA will make this remarkable drug available to million of women in the US so they can finally get relief from a very real problem of low libido. Although it has been shown to be safe and very effective worldwide, the added safety of having FDA approval, US manufacturing quality standards, the convenience of an autoinjector rather than reconstituting it for IM injection, and the potential for price discounts for insurance payors or pharmacy buyers makes this drug much more attractive to US consumers than buying it from China.

There is some weird stigma attached to any drug that affects a women’s libido in this country which probably explains the initial FDA ban. Now that we are past that childish debate women can legally treat low libido with the same confidence that they treat depression or bi-polar disorder or other medical conditions once thought to be “just in your head”. Both AMAG Pharmaceuticals and Palatin Technologies have been trashed by the stock market since the approval but once the earnings start showing up I think the shorts will get routed and the stocks will explode.